SEC Form 4 · accession 0001144204-15-013674
Celator Pharmaceuticals Inc · CPXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jean-Pierre Bizzari
Director
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001327467
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option, Right to BuyF1 | $2.77 | Feb 27, 2015 | A | 28,000 | A | — | Feb 27, 2025 | Common Stock | 28,000 | 28,000 | D |
Explanation of responses
- F1The options vest as follows: (i) 9,334 options vest on February 27, 2016; (ii) 7 consecutive quarterly installments of 2,333 options vest on the 27th day of each May, August, November and February, beginning May 25, 2016 and continuing through November 25, 2017 (iii) 2.335 options vest on February 27, 2018.